Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 1/2023

Open Access 01-12-2023 | Vaccination | Research

COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions

Authors: Brianna A. Smith, Emily E. Ricotta, Jennifer L. Kwan, Nicholas G. Evans

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2023

Login to get access

Abstract

Background

COVID-19 disproportionately affects those with preexisting conditions, but little research has determined whether those with chronic diseases view the pandemic itself differently - and whether there are differences between chronic diseases. We theorized that while individuals with respiratory disease or autoimmune disorders would perceive greater threat from COVID-19 and be more supportive of non-pharmaceutical interventions (NPIs), those with autoimmune disorders would be less likely to support vaccination-based interventions.

Methods

We conducted a two-wave online survey conducted in February and November 2021 asking respondents their beliefs about COVID-19 risk perception, adoption and support of interventions, willingness to be vaccinated against COVID-19, and reasons for vaccination. Regression analysis was conducted to assess the relationship of respondents reporting a chronic disease and COVID-19 behaviors and attitudes, compared to healthy respondents adjusting for demographic and political factors.

Results

In the initial survey, individuals reporting a chronic disease had both stronger feelings of risk from COVID-19 as well as preferences for NPIs than healthy controls. The only NPI that was still practiced significantly more compared to healthy controls in the resample was limiting trips outside of the home. Support for community-level NPIs was higher among individuals reporting a chronic disease than healthy controls and remained high among those with respiratory diseases in sample 2. Vaccine acceptance produced more divergent results: those reporting chronic respiratory diseases were 6% more willing to be vaccinated than healthy controls, while we found no significant difference between individuals with autoimmune diseases and healthy controls. Respondents with chronic respiratory disease and those with autoimmune diseases were more likely to want to be vaccinated to protect themselves from COVID-19, and those with an autoimmune disease were more likely to report fear of a bad vaccine reaction as the reason for vaccine hesitancy. In the resample, neither those with respiratory diseases nor autoimmune diseases reported being more willing to receive a booster vaccine than healthy controls.

Conclusions

It is not enough to recognize the importance of health in determining attitudes: nuanced differences between conditions must also be recognized.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar;28(10229):1054–62. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar;28(10229):1054–62.
2.
go back to reference Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS ONE. 2020 Aug;26(8):e0238215. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS ONE. 2020 Aug;26(8):e0238215.
3.
go back to reference Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, Comorbidities, and Outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020 May;26(20):2052–9. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, Comorbidities, and Outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020 May;26(20):2052–9.
4.
go back to reference Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis. Clin Cardiol. 2020;43(12):1478–93.CrossRefPubMedPubMedCentral Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis. Clin Cardiol. 2020;43(12):1478–93.CrossRefPubMedPubMedCentral
6.
go back to reference Vally Z. Public perceptions, anxiety and the perceived efficacy of health-protective behaviours to mitigate the spread of the SARS-Cov-2/ COVID-19 pandemic. Public Health. 2020 Oct;187:67–73. Vally Z. Public perceptions, anxiety and the perceived efficacy of health-protective behaviours to mitigate the spread of the SARS-Cov-2/ COVID-19 pandemic. Public Health. 2020 Oct;187:67–73.
7.
go back to reference Nguyen KH. COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020. MMWR Morb Mortal Wkly Rep;70 Nguyen KH. COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020. MMWR Morb Mortal Wkly Rep;70
8.
go back to reference Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel);9(1) Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel);9(1)
10.
go back to reference Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH et al. Chronic Obstructive Pulmonary Disease in America’s Black Population. Am J Respir Crit Care Med. 2019 Feb 21;200(4):423–30. Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH et al. Chronic Obstructive Pulmonary Disease in America’s Black Population. Am J Respir Crit Care Med. 2019 Feb 21;200(4):423–30.
12.
go back to reference Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Frontiers in Neuroendocrinology. 2014 Aug 1;35(3):347–69. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Frontiers in Neuroendocrinology. 2014 Aug 1;35(3):347–69.
14.
go back to reference Evans NG, Reynolds JM, Johnson KR. Moving through capacity space: mapping disability and enhancement. J Med Ethics. 2021 Nov;47(11):748–55. Evans NG, Reynolds JM, Johnson KR. Moving through capacity space: mapping disability and enhancement. J Med Ethics. 2021 Nov;47(11):748–55.
15.
go back to reference Barbhaiya M, Levine JM, Bykerk VP, et al. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis. 2021;80:1352.CrossRefPubMed Barbhaiya M, Levine JM, Bykerk VP, et al. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis. 2021;80:1352.CrossRefPubMed
16.
go back to reference Xie Y, Liu Y, Liu Y. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.Frontiers in Immunology2022;13. Xie Y, Liu Y, Liu Y. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.Frontiers in Immunology2022;13.
17.
go back to reference Ferri C, Ursini F, Gragnani L, et al. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups. J Autoimmun. 2021;125:102744.CrossRefPubMedPubMedCentral Ferri C, Ursini F, Gragnani L, et al. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups. J Autoimmun. 2021;125:102744.CrossRefPubMedPubMedCentral
18.
go back to reference Palan S, Schitter C. Prolific.ac—A subject pool for online experiments. J Behav Experimental Finance. 2018 Mar;1:17:22–7. Palan S, Schitter C. Prolific.ac—A subject pool for online experiments. J Behav Experimental Finance. 2018 Mar;1:17:22–7.
19.
go back to reference Peer E, Brandimarte L, Samat S, Acquisti A. Beyond the Turk: alternative platforms for crowdsourcing behavioral research. J Exp Soc Psychol. 2017;70:153–63.CrossRef Peer E, Brandimarte L, Samat S, Acquisti A. Beyond the Turk: alternative platforms for crowdsourcing behavioral research. J Exp Soc Psychol. 2017;70:153–63.CrossRef
20.
go back to reference Johansson B, Starmark A, Berglund P, Rödholm M, Rönnbäck L. A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Inj. 2010 Jan;24(1):2–12. Johansson B, Starmark A, Berglund P, Rödholm M, Rönnbäck L. A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Inj. 2010 Jan;24(1):2–12.
21.
22.
go back to reference Henningsen A, Hamann JD. systemfit: A Package for estimating Systems of simultaneous equations in R. J Stat Softw. 2007;23(4):1–40.CrossRef Henningsen A, Hamann JD. systemfit: A Package for estimating Systems of simultaneous equations in R. J Stat Softw. 2007;23(4):1–40.CrossRef
24.
go back to reference Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J et al. Perspective of patients with autoimmune diseases on COVID-19 vaccination. The Lancet Rheumatology. 2021 Feb;S2665991321000370. Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J et al. Perspective of patients with autoimmune diseases on COVID-19 vaccination. The Lancet Rheumatology. 2021 Feb;S2665991321000370.
25.
go back to reference Barnes E. The Minority Body: A Theory of Disability. 1st Edition. Oxford, United Kingdom: Oxford University Press; 2016. Barnes E. The Minority Body: A Theory of Disability. 1st Edition. Oxford, United Kingdom: Oxford University Press; 2016.
27.
go back to reference SteelFisher GK, Blendon RJ, Caporello H. An uncertain public—encouraging acceptance of Covid-19 vaccines. New England Journal of Medicine. 2021 Apr 22;384(16):1483-7. SteelFisher GK, Blendon RJ, Caporello H. An uncertain public—encouraging acceptance of Covid-19 vaccines. New England Journal of Medicine. 2021 Apr 22;384(16):1483-7.
28.
go back to reference Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, et al. Intention to get vaccinations against COVID-19 in french healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect. 2021 Feb;1:108:168–73. Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, et al. Intention to get vaccinations against COVID-19 in french healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect. 2021 Feb;1:108:168–73.
29.
go back to reference Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020 Oct 21;38(45):7002–6. Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020 Oct 21;38(45):7002–6.
30.
go back to reference Ungaro RC, Agrawal M, Park S, Hirten R, Colombel JF, Twyman K, et al. Autoimmune and chronic inflammatory disease patients with COVID-19. ACR Open Rheumatology. 2021;3(2):111–5.CrossRefPubMedPubMedCentral Ungaro RC, Agrawal M, Park S, Hirten R, Colombel JF, Twyman K, et al. Autoimmune and chronic inflammatory disease patients with COVID-19. ACR Open Rheumatology. 2021;3(2):111–5.CrossRefPubMedPubMedCentral
31.
go back to reference Murata K, Nakao N, Ishiuchi N et al. Four cases of cytokine storm after COVID-19 vaccination: Case report.Frontiers in Immunology2022;13. Murata K, Nakao N, Ishiuchi N et al. Four cases of cytokine storm after COVID-19 vaccination: Case report.Frontiers in Immunology2022;13.
32.
go back to reference Watad A, De Marco G, Mahajna H, et al. Immune-Mediated Disease Flares or New-Onset Disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9:435.CrossRefPubMedPubMedCentral Watad A, De Marco G, Mahajna H, et al. Immune-Mediated Disease Flares or New-Onset Disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9:435.CrossRefPubMedPubMedCentral
33.
go back to reference Buyuktiryaki B, Soyer OU, Erkocoglu M, Dogan A, Azkur D, Kocabas CN, et al. What a pandemic teaches us about vaccination attitudes of parents of children with asthma. Vaccine. 2014 Apr;32(20):2275–80. Buyuktiryaki B, Soyer OU, Erkocoglu M, Dogan A, Azkur D, Kocabas CN, et al. What a pandemic teaches us about vaccination attitudes of parents of children with asthma. Vaccine. 2014 Apr;32(20):2275–80.
34.
go back to reference Toh MPHS, Kannan P, Chen Y, Chng FLC, Tang WE. Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference? Vaccine. 2012 Feb;30(6):1064–70. Toh MPHS, Kannan P, Chen Y, Chng FLC, Tang WE. Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference? Vaccine. 2012 Feb;30(6):1064–70.
35.
go back to reference Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Soc Sci Med. 2014 Jul;112:1–11. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Soc Sci Med. 2014 Jul;112:1–11.
36.
go back to reference Hidiroglu S, Ay P, Topuzoglu A, Kalafat C, Karavus M. Resistance to vaccination: the attitudes and practices of primary healthcare workers confronting the H1N1 pandemic. Vaccine. 2010 Nov;28(51):8120–4. Hidiroglu S, Ay P, Topuzoglu A, Kalafat C, Karavus M. Resistance to vaccination: the attitudes and practices of primary healthcare workers confronting the H1N1 pandemic. Vaccine. 2010 Nov;28(51):8120–4.
37.
go back to reference Hagger MS, Hamilton K. Predicting COVID-19 booster vaccine intentions.Applied Psych Health & Well. 2022 Feb 22;aphw.12349. Hagger MS, Hamilton K. Predicting COVID-19 booster vaccine intentions.Applied Psych Health & Well. 2022 Feb 22;aphw.12349.
39.
go back to reference World Health Organization. Regional Office for Europe. Pandemic fatigue: reinvigorating the public to prevent COVID-19: policy considerations for Member States in the WHO European Region [Internet]. World Health Organization. Regional Office for Europe. ; 2020 [cited 2022 Jun 9]. Report No.: WHO/EURO:2020-1160-40906-55390. Available from: https://apps.who.int/iris/handle/10665/335820 World Health Organization. Regional Office for Europe. Pandemic fatigue: reinvigorating the public to prevent COVID-19: policy considerations for Member States in the WHO European Region [Internet]. World Health Organization. Regional Office for Europe. ; 2020 [cited 2022 Jun 9]. Report No.: WHO/EURO:2020-1160-40906-55390. Available from: https://​apps.​who.​int/​iris/​handle/​10665/​335820
Metadata
Title
COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions
Authors
Brianna A. Smith
Emily E. Ricotta
Jennifer L. Kwan
Nicholas G. Evans
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2023
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/s13223-023-00791-6

Other articles of this Issue 1/2023

Allergy, Asthma & Clinical Immunology 1/2023 Go to the issue